期刊文献+

突发性聋患者血清AT-Ⅲ、PAI-1的检测及其临床意义 被引量:3

Changes of AT-Ⅲ and PAI-1 in the Blood of Patients With Sudden Sensorineural Hearing Loss
下载PDF
导出
摘要 目的探讨抗凝血酶Ⅲ(AT-Ⅲ)和纤溶酶原激活剂抑制物-1(PAI-1)活性水平变化与突发性聋发病的关系。方法应用发色底物法测定不同病程的突发性聋患者44例和30例健康者血清AT-Ⅲ和PAI-1活性水平,并进行统计学比较。结果AT-Ⅲ、PAI-1活性水平的改变与突发性聋病程有关。发病3天内与发病一周以上患者比较,前者的血清AT-Ⅲ水平低于后者、而血清PAI-1活性水平高于后者,两者有显著差异(P<0.05);病程一周以上患者与对照组相比血清AT-Ⅲ、PAT-1活性水平无显著性差异。结论突发性聋患者三天内血清AT-Ⅲ、PAI-1活性水平的改变提示血凝与纤溶障碍与其发病有关。 Objective To study the changes of AT-III and PAI-1 in the blood of patients with sudden sensorineural hearing loss(SSHL) and investigate the relationship between their levels and the disease.Methods The levels of AT-III and PAI-1 in the blood of 44 patients with SSHL and 30 healthy volunteers were detected using chromogentic substrate method.Results The changes of AT-III and PAI-1 in the blood of patients with SSHL were correlated with the process of the disease.There was significant difference between the levels of AT-III and PAI-1 in the blood of patients within 3 days and that of patients beyond 1 week(P<0.05),and there was no significant difference between the latter and control group. Conclusion The level of AT-III and PAI-1 in the blood of patients with SSHL within 3 days changes,which suggests that the dysfunction of blood coagulation and fiber dissolution corretate with the SSHL.
出处 《听力学及言语疾病杂志》 CAS CSCD 2005年第4期251-252,共2页 Journal of Audiology and Speech Pathology
关键词 突发性聋 抗凝血酶Ⅲ 纤溶酶原激活剂抑制物-1 Sudden sensorineural hearing loss AT-III PAI-1
  • 相关文献

参考文献8

二级参考文献10

  • 1赵海霞.组织型纤溶酶原激活物研究进展[J].国外医学(输血及血液学分册),1995,18(1):19-23. 被引量:21
  • 2TadadaA,TakadaY.Thephysiologicalaspectsoffibriolysis[J].ThrombRes,1994;76(1):1.[J].
  • 3RylattDB,BlakcAS,CottisLE.AnimmunoassayforhumanD-dimerusingmonoclonalantibodies[J].Thrombres,1983;31:767.
  • 4EritslandJ,SeljeflotI,ArnesenI,etal.Effectsoflongtermtreatmentwithwarfarinonfibrinogen,FPA,TATandD-dimerinpatientswithcoronaryarterydiseae[J].ThrombRes,1992;66:55.
  • 5AraiH,MiyakawaT,QzakikS,etal.ChangesofthelevelofantithrombinⅢpatientswithcerebrovasculardisease[J].ThrombRes,1983;3:197.
  • 6StrugerHAR,StietenP,HeijnerHFG,etal.Plassminogenactivator-1releadedplatelatplaysakeyroleinthrombosisresistance:studieswiththrombigeneratedinthechandleloop[J].ArteriosclerThromb,1994;14(8):1452
  • 7TakanoD,HaimingC.Markersofhypercoagulablestatefollowingacuteischmic[J].Stroke,1992;23:194.
  • 8FeinbergWM,BruckDC,RingME,etal.Hemostaticmarkersinacutestroke[J].Stroke,1989;20:592
  • 9中国人民解放军后勤部卫生部.医药卫生科学技术进展[M]人民军医出版社,1992.
  • 10王福生,吴祖泽.白细胞介素-6(IL-6)研究进展[J].国外医学(免疫学分册),1990,13(4):169-173. 被引量:11

共引文献25

同被引文献41

引证文献3

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部